Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Covance
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Covance
-
Prikvačeni tweet
Discover where you are on your path to clinical transformation and how Covance Clinical can help. http://bit.ly/CovanceClinical
#CovanceClinical#ClinicalDevelopment#ingenuity4pic.twitter.com/5o3Bip3GJx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to have participated and to help support the next generation of scientists!https://twitter.com/UWContinStudies/status/1225112623106097156 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Covance proslijedio/la je Tweet
Join the
@Covance 2020 Global Internship Program this year! Work assignments revolve around STEM+ and healthcare fields. Interns will have the chance to see firsthand how Covance is dedicated to its community through philanthropic projects, as well! https://careers.college.indiana.edu/jobs/covance-laboratories-inc-covance-2020-global-internship-program/ …pic.twitter.com/sL8yBZqOjx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As clinical studies get more complex, trial sponsors are seeking more efficient ways to leverage data to better execute studies. Learn what data is essential for better decision making and trial acceleration. http://bit.ly/3715KjZ
#clinicaltrials#biotechpic.twitter.com/M29kloXuYw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Rare Disease Day is February 29th. Rare is many. Rare is strong. Rare is proud. Join us in sharing your support.
#reframerare,#rarediseasedaypic.twitter.com/pbhmSvgFfQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Find out how to implement a systematic forced degradation strategy, resulting in defined degradation conditions and time points in this upcoming webinar. http://bit.ly/30NlxRx?cid=c07a0b26-f162-4e00-bf80-769220b2ddda …pic.twitter.com/jZJSapcswr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join us for a one-day event exploring the challenges and issues in a changing chemicals landscape. http://bit.ly/2GsNvZx
#ChemSymposiumpic.twitter.com/ETXWpKzL9u
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Louise Kearney and Melissa Harris to learn how Covance is leveraging our proprietary tools and real world data sets to design and conduct studies focused on the needs of patients and their families. http://bit.ly/2OoD0uO
#patientrecruitment#patientvoicepic.twitter.com/fJZjMCE4w3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Save the date for our webinar: Applying Data Analytics and a Decentralized Trial Platform for More Efficient Patient-Centric Trials. Tuesday, February 25 @ 11 a.m. – 12 p.m. CST |Register today: http://bit.ly/35UIX8D
#clinicalresearch#patientcentricitypic.twitter.com/VXiVZMWxTH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How do cell and gene therapies fit in the
#bioanalytical space? Register to learn more during the@BioanalysisZone Coffee Chat with Paul Byrne - Principal Scientist, Covance.http://bit.ly/3aLK0eDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Outsourcing in the Cell & Gene Therapy Space - Steven Anderson PhD, CSO Covance, explains how specialized and coordinated capabilities aim to accelerate
#drugdevelopment and reduce risk for sponsors. http://bit.ly/2RS73gi#cellandgenetherapypic.twitter.com/UED0l0XeW4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Louise Kearney and Melissa Harris to learn how Covance is leveraging our proprietary tools and real world data sets to design and conduct studies focused on the needs of patients and their families. http://bit.ly/2OoD0uO
#patientrecruitment#patientvoicepic.twitter.com/duqfrdlqps
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Covance proslijedio/la je Tweet
In this exclusive interview, Robert Nelson of
@Covance (Geneva, Switzerland) discusses biomarkers in drug development, describing the strategies and techniques Covance utilize to effectively develop and validate biomarker assays - http://bit.ly/3aRQY1B pic.twitter.com/hZ5rOf7AiL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Need better data management in the lab? Find out how you can improve your data readiness and bridge the gap between the lab and clinical CROs for more efficient, optimized studies. Learn more: http://bit.ly/2vCczLl
#FSPx#ClinicalCROpic.twitter.com/JWrYfdwbSx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Only 10-20% of
#clinicaltrials meet enrollment timelines while roughly 80% don’t finish on time. We leverage unique-to-the-industry data sets and tech applications that provide actionable insights and powerful results. Watch the video http://bit.ly/2soOBlw#realworlddatapic.twitter.com/w0PNdc2qUa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How do you define success of your risk-based quality approach? Do you have one set of metrics in place for your organization – and can they be improved? Join our educational webinar on Feb. 4 as we discuss these questions and more. http://bit.ly/38IM4SL pic.twitter.com/MjbiFbJd7h
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How do you define success of your risk-based quality approach? Do you have one set of metrics in place for your organization – and can they be improved? Join our educational webinar on Feb. 4 as we discuss these questions and more. http://bit.ly/38IM4SL pic.twitter.com/nQ2BSQdvbR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Putting Patient Convenience First: Creating Next-Generation Product Access Support Programs that Drive Engagement and Utilization http://bit.ly/PatientsFirstOnDemand …
#patientfocus#patientsfirst#clinicaltrialspic.twitter.com/3FEIWTeUQ5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Covance has unique-to-the-industry proprietary data sets working together to provide actionable insights to accelerate
#patientrecruitment. Watch the video > http://ow.ly/s25T50xXkYX#clinicaltrials#realworlddata#realimpactpic.twitter.com/Xm5waex9Vk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Covance proslijedio/la je Tweet
Two announcements this week about large players investing in cell & gene therapy. This time,
@Covance announces a new suite of offerings to help sponsors reduce development time and risk. More>> http://bit.ly/2RDaXJP@LabCorp@fiercebiotech#preclinicaldevelopment#CROpic.twitter.com/0cBA8HhSha
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Covance proslijedio/la je Tweet
Robert Nelson (
@Covance) Geneva, Switzerland) discusses the importance of biomarkers in drug development, describing key aspects in the current guidance and key considerations to make in the development and validation process. Watch the full interview now: http://bit.ly/3aRQY1B pic.twitter.com/Xc4iJGfoZX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.